{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:54:25Z","timestamp":1781182465119,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,9]]},"DOI":"10.7759\/cureus.44964","type":"journal-article","created":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:16:33Z","timestamp":1694304993000},"source":"Crossref","is-referenced-by-count":1,"title":["A Practical Overview of the Articular Manifestations of Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Juan Camilo","family":"Santacruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Juliana","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ram\u00f3n","family":"Isaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Londono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135186","article-title":"Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade","volume":"69","author":"Bertsias GK","year":"2010","unstructured":"Bertsias GK, Salmon JE, Boumpas DT. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis. 2010, 69:1603-11. 10.1136\/ard.2010.135186","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"10188","author":"Durcan L","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet . 2019, 10188:2332-43. 10.1016\/S0140-6736(19)30237-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus","volume":"72","author":"Cervera R","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J, et al.. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993, 72:113-24.","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.022","article-title":"Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment","volume":"47","author":"Ceccarelli F","year":"2017","unstructured":"Ceccarelli F, Perricone C, Cipriano E, et al.. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017, 47:53-64. 10.1016\/j.semarthrit.2017.03.022","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130704","article-title":"American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort","volume":"41","author":"Urowitz MB","year":"2014","unstructured":"Urowitz MB, Gladman DD, Iba\u00f1ez D, et al.. American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort. J Rheumatol. 2014, 41:875-80. 10.3899\/jrheum.130704","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-86. 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3670-y","article-title":"Ultrasound evaluation of joints in systemic lupus erythematosus: a systematic review","volume":"25","author":"Lins CF","year":"2015","unstructured":"Lins CF, Santiago MB. Ultrasound evaluation of joints in systemic lupus erythematosus: a systematic review. Eur Radiol. 2015, 25:2688-92. 10.1007\/s00330-015-3670-y","journal-title":"Eur Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker381","article-title":"Lupus arthritis--do we have a clinically useful classification?","volume":"51","author":"Ball EM","year":"2012","unstructured":"Ball EM, Bell AL. Lupus arthritis--do we have a clinically useful classification?. Rheumatology (Oxford). 2012, 51:771-9. 10.1093\/rheumatology\/ker381","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2008.01.017","article-title":"Deforming arthropathy in systemic lupus erythematosus","volume":"19","author":"Pipili C","year":"2008","unstructured":"Pipili C, Sfritzeri A, Cholongitas E. Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med. 2008, 19:482-7. 10.1016\/j.ejim.2008.01.017","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2009.04.003","article-title":"Lupus arthritis","volume":"23","author":"Grossman JM","year":"2009","unstructured":"Grossman JM. Lupus arthritis. Best Pract Res Clin Rheumatol. 2009, 23:495-506. 10.1016\/j.berh.2009.04.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.10753","article-title":"Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging","volume":"48","author":"Ostendorf B","year":"2003","unstructured":"Ostendorf B, Scherer A, Specker C, M\u00f6dder U, Schneider M. Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum. 2003, 48:157-65. 10.1002\/art.10753","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-857X(21)00949-2","article-title":"Musculoskeletal manifestations of systemic lupus erythematosus","volume":"14","author":"Cronin ME","year":"1988","unstructured":"Cronin ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 1988, 14:99-116.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.12.2.101","article-title":"The relation between heart and joint disease including \"rheumatoid heart disease\" and chronic post rheumatic arthritis (type Jaccoud)","volume":"12","author":"BY EG","year":"1950","unstructured":"BY EG. The relation between heart and joint disease including \"rheumatoid heart disease\" and chronic post rheumatic arthritis (type Jaccoud). Br Heart J. 1950, 12:101-31. 10.1136\/hrt.12.2.101","journal-title":"Br Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.10.018","article-title":"Miscellaneous non-inflammatory musculoskeletal conditions. Jaccoud's arthropathy","volume":"25","author":"Santiago MB","year":"2011","unstructured":"Santiago MB. Miscellaneous non-inflammatory musculoskeletal conditions. Jaccoud's arthropathy. Best Pract Res Clin Rheumatol. 2011, 25:715-25. 10.1016\/j.berh.2011.10.018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref15","article-title":"Jaccoud's arthropathy with vasculitis and primary Sj\u00f6gren's syndrome. A new entity","volume":"24","author":"Ballard M","year":"2006","unstructured":"Ballard M, Meyer O, Adle-Biassette H, Grossin M. Jaccoud's arthropathy with vasculitis and primary Sj\u00f6gren's syndrome. A new entity. Clin Exp Rheumatol. 2006, 24:S102-3.","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","article-title":"Jaccoud's arthropathy in scleroderma","volume":"2","author":"Bradley JD","year":"1984","unstructured":"Bradley JD, Pinals RS. Jaccoud's arthropathy in scleroderma. Clin Exp Rheumatol. 1984, 2:337-40.","journal-title":"Clin Exp Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semreu.2010.10.001","article-title":"Jaccoud arthropathy: more than just lupus [Article in Spanish]","volume":"12","author":"L\u00f3pez Longo FJ","year":"2011","unstructured":"L\u00f3pez Longo FJ. Jaccoud arthropathy: more than just lupus [Article in Spanish]. Semin la Fund Espa\u00f1ola Reumatol. 2011, 12:36-41. 10.1016\/j.semreu.2010.10.001","journal-title":"Semin la Fund Espa\u00f1ola Reumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a023c8","article-title":"The senescent form of Jaccoud arthropathy","volume":"15","author":"Arlet JB","year":"2009","unstructured":"Arlet JB, Pouchot J. The senescent form of Jaccoud arthropathy. J Clin Rheumatol. 2009, 15:151. 10.1097\/RHU.0b013e3181a023c8","journal-title":"J Clin Rheumatol"},{"key":"ref19","article-title":"Jaccoud's-type arthropathy: an association with malignancy","volume":"16","author":"Johnson JJ","year":"1989","unstructured":"Johnson JJ, Leonard-Segal A, Nashel DJ. Jaccoud's-type arthropathy: an association with malignancy. J Rheumatol. 1989, 16:1278-80.","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/BF02238765","article-title":"Jaccoud's arthropathy of the hands in overlap syndrome","volume":"16","author":"Paredes JG","year":"1997","unstructured":"Paredes JG, Lazaro MA, Citera G, Da Representacao S, Maldonado Cocco JA. Jaccoud's arthropathy of the hands in overlap syndrome. Clin Rheumatol. 1997, 16:65-9. 10.1007\/BF02238765","journal-title":"Clin Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01040-8","article-title":"Imaging of joint and soft tissue involvement in systemic lupus erythematosus","volume":"23","author":"Di Matteo A","year":"2021","unstructured":"Di Matteo A, Smerilli G, Cipolletta E, et al.. Imaging of joint and soft tissue involvement in systemic lupus erythematosus. Curr Rheumatol Rep. 2021, 23:73. 10.1007\/s11926-021-01040-8","journal-title":"Curr Rheumatol Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/096120339400300510","article-title":"Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA\/Ro and to SSB\/La","volume":"3","author":"Franceschini F","year":"1994","unstructured":"Franceschini F, Cretti L, Quinzanini M, Rizzini FL, Cattaneo R. Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA\/Ro and to SSB\/La. Lupus. 1994, 3:419-22. 10.1177\/096120339400300510","journal-title":"Lupus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/s101650170043","article-title":"Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy","volume":"11","author":"Takeishi M","year":"2001","unstructured":"Takeishi M, Mimori A, Suzuki T. Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy. Mod Rheumatol. 2001, 11:47-51. 10.3109\/s101650170043","journal-title":"Mod Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.09.004","article-title":"Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients","volume":"12","author":"Tani C","year":"2013","unstructured":"Tani C, D'Aniello D, Delle Sedie A, et al.. Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2013, 12:537-41. 10.1016\/j.autrev.2012.09.004","journal-title":"Autoimmun Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2010.12.006","article-title":"Rhupus: report of 4 cases [Article in Spanish]","volume":"7","author":"Benavente EP","year":"2011","unstructured":"Benavente EP, Paira SO. Rhupus: report of 4 cases [Article in Spanish]. Reumatol Clin. 2011, 7:333-5. 10.1016\/j.reuma.2010.12.006","journal-title":"Reumatol Clin"},{"key":"ref26","article-title":"Three case reports of rhupus syndrome: an overlap syndrome of rheumatoid arthritis and systemic lupus erythematosus","volume":"2018","author":"Devrimsel G","year":"2018","unstructured":"Devrimsel G, Serdaroglu Beyazal M. Three case reports of rhupus syndrome: an overlap syndrome of rheumatoid arthritis and systemic lupus erythematosus. Case Rep Rheumatol. 2018, 2018:1-3.","journal-title":"Case Rep Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29018","article-title":"Rhupus syndrome: a diagnostic dilemma","volume":"14","author":"Upadhyaya S","year":"2022","unstructured":"Upadhyaya S, Agarwal M, Upadhyaya A, Pathania M, Dhar M. Rhupus syndrome: a diagnostic dilemma. Cureus. 2022, 14:e29018. 10.7759\/cureus.29018","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102612","article-title":"Rhupus: a systematic literature review","volume":"19","author":"Antonini L","year":"2020","unstructured":"Antonini L, Le Mauff B, Marcelli C, Aouba A, de Boysson H. Rhupus: a systematic literature review. Autoimmun Rev. 2020, 19:102612. 10.1016\/j.autrev.2020.102612","journal-title":"Autoimmun Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314526439","article-title":"Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients","volume":"23","author":"Liu T","year":"2014","unstructured":"Liu T, Li G, Mu R, Ye H, Li W, Li Z. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus. 2014, 23:958-63. 10.1177\/0961203314526439","journal-title":"Lupus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreu.2021.05.003","article-title":"Diagnosis and treatment of articular manifestations of systemic lupus erythematosus","volume":"28","author":"Frade-Sosa B","year":"2021","unstructured":"Frade-Sosa B, Sarmiento-Monroy JC, Salman-Monte TC, et.al.. Diagnosis and treatment of articular manifestations of systemic lupus erythematosus. Rev Colomb Reumatol . 2021, 28:90-100. 10.1016\/j.rcreu.2021.05.003","journal-title":"Rev Colomb Reumatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura K","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, et al.. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007, 146:797-808. 10.7326\/0003-4819-146-11-200706050-00008","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1990.4","article-title":"Antibodies to type II collagen in SLE: a role in the pathogenesis of deforming arthritis?","volume":"68 ( Pt 1)","author":"Choi EK","year":"1990","unstructured":"Choi EK, Gatenby PA, Bateman JF, Cole WG. Antibodies to type II collagen in SLE: a role in the pathogenesis of deforming arthritis?. Immunol Cell Biol. 1990, 68 ( Pt 1):27-31. 10.1038\/icb.1990.4","journal-title":"Immunol Cell Biol"},{"key":"ref33","article-title":"Tendinous laxity and Jaccoud's syndrome in patients with systemic lupus erythematosus. Possible role of secondary hyperparathyroidism","volume":"16","author":"Babini SM","year":"1989","unstructured":"Babini SM, Cocco JA, de la Sota M, Babini JC, Arturi A, Marcos JC, Morteo OG. Tendinous laxity and Jaccoud's syndrome in patients with systemic lupus erythematosus. Possible role of secondary hyperparathyroidism. J Rheumatol. 1989, 16:494-8.","journal-title":"J Rheumatol"},{"key":"ref34","article-title":"Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes","volume":"28","author":"Chen HJ","year":"2001","unstructured":"Chen HJ, Bloch KJ. Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes. J Rheumatol. 2001, 28:383-6.","journal-title":"J Rheumatol"},{"key":"ref35","article-title":"Arthropathy of hands and feet in systemic lupus erythematosus","volume":"17","author":"Reilly PA","year":"1990","unstructured":"Reilly PA, Evison G, McHugh NJ, Maddison PJ. Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol. 1990, 17:777-84.","journal-title":"J Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316662723","article-title":"Entheseal involvement in systemic lupus erythematosus: are we missing something?","volume":"26","author":"Di Matteo A","year":"2017","unstructured":"Di Matteo A, Satulu I, Di Carlo M, Lato V, Filippucci E, Grassi W. Entheseal involvement in systemic lupus erythematosus: are we missing something?. Lupus. 2017, 26:320-8. 10.1177\/0961203316662723","journal-title":"Lupus"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2012.09.016","article-title":"Hand and wrist arthralgia in systemic lupus erythematosus is associated to ultrasonographic abnormalities","volume":"80","author":"Torrente-Segarra V","year":"2013","unstructured":"Torrente-Segarra V, Lisbona MP, Rot\u00e9s-Sala D, et al.. Hand and wrist arthralgia in systemic lupus erythematosus is associated to ultrasonographic abnormalities. Jt Bone Spine. 2013, 80:402-6.","journal-title":"Jt Bone Spine"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes226","article-title":"Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients","volume":"51","author":"Gabba A","year":"2012","unstructured":"Gabba A, Piga M, Vacca A, Porru G, Garau P, Cauli A, Mathieu A. Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients. Rheumatology (Oxford). 2012, 51:2278-85. 10.1093\/rheumatology\/kes226","journal-title":"Rheumatology (Oxford)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu215","article-title":"A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status","volume":"53","author":"Ball EM","year":"2014","unstructured":"Ball EM, Tan AL, Fukuba E, et al.. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status. Rheumatology (Oxford). 2014, 53:1835-43. 10.1093\/rheumatology\/keu215","journal-title":"Rheumatology (Oxford)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key189","article-title":"Entheseal involvement in patients with systemic lupus erythematosus: an ultrasound study","volume":"57","author":"Di Matteo A","year":"2018","unstructured":"Di Matteo A, Filippucci E, Cipolletta E, et al.. Entheseal involvement in patients with systemic lupus erythematosus: an ultrasound study. Rheumatology (Oxford). 2018, 57:1822-9. 10.1093\/rheumatology\/key189","journal-title":"Rheumatology (Oxford)"},{"key":"ref41","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman DD","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002, 29:288-91.","journal-title":"J Rheumatol"},{"key":"ref42","article-title":"Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus","volume":"1","author":"Isenberg DA","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, et al.. Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus. Rheumatology . 2005, 1:902-6.","journal-title":"Rheumatology"},{"key":"ref43","article-title":"Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus","volume":"21","author":"Williams HJ","year":"1994","unstructured":"Williams HJ, Egger MJ, Singer JZ, et al.. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J Rheumatol. 1994, 21:1457-62.","journal-title":"J Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu204oa","article-title":"Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE","volume":"11","author":"Lander SA","year":"2002","unstructured":"Lander SA, Wallace DJ, Weisman MH. Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE. Lupus. 2002, 11:340-7. 10.1191\/0961203302lu204oa","journal-title":"Lupus"},{"key":"ref45","article-title":"Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis","volume":"25","author":"Rahman P","year":"1998","unstructured":"Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol. 1998, 25:243-6.","journal-title":"J Rheumatol"},{"key":"ref46","article-title":"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus","volume":"26","author":"Carneiro JR","year":"1999","unstructured":"Carneiro JR, Sato EI. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol. 1999, 26:1275-9.","journal-title":"J Rheumatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1154943","article-title":"Abatacept for the treatment of systemic lupus erythematosus","volume":"25","author":"Pimentel-Quiroz VR","year":"2016","unstructured":"Pimentel-Quiroz VR, Ugarte-Gil MF, Alarc\u00f3n GS. Abatacept for the treatment of systemic lupus erythematosus. Expert Opin Investig Drugs. 2016, 25:493-9. 10.1517\/13543784.2016.1154943","journal-title":"Expert Opin Investig Drugs"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/art.39085","article-title":"Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus","volume":"67","author":"Vital EM","year":"2015","unstructured":"Vital EM, Wittmann M, Edward S, et al.. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis Rheumatol. 2015, 67:1586-91. 10.1002\/art.39085","journal-title":"Arthritis Rheumatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra SV","year":"2011","unstructured":"Navarra SV, Guzm\u00e1n RM, Gallacher AE, et al.. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011, 377:721-31. 10.1016\/S0140-6736(10)61354-2","journal-title":"Lancet"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie R","year":"2011","unstructured":"Furie R, Petri M, Zamani O, et al.. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011, 63:3918-30. 10.1002\/art.30613","journal-title":"Arthritis Rheum"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010668.pub2","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh JA","year":"2021","unstructured":"Singh JA, Shah NP, Mudano AS. Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021, 2:CD010668. 10.1002\/14651858.CD010668.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie R","year":"2017","unstructured":"Furie R, Khamashta M, Merrill JT, et al.. Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheumatol. 2017, 69:376-86. 10.1002\/art.39962","journal-title":"Arthritis Rheumatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11414","article-title":"Interferon inhibition for lupus with anifrolumab: critical appraisal of the evidence leading to FDA approval","volume":"4","author":"Loncharich MF","year":"2022","unstructured":"Loncharich MF, Anderson CW. Interferon inhibition for lupus with anifrolumab: critical appraisal of the evidence leading to FDA approval. ACR Open Rheumatol. 2022, 4:486-91. 10.1002\/acr2.11414","journal-title":"ACR Open Rheumatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand EF","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, et al.. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020, 382:211-21. 10.1056\/NEJMoa1912196","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000284","article-title":"Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus","volume":"5","author":"Merrill JT","year":"2018","unstructured":"Merrill JT, Furie R, Werth VP, et al.. Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus. Lupus Sci Med. 2018, 5:e000284. 10.1136\/lupus-2018-000284","journal-title":"Lupus Sci Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-83-5-597","article-title":"Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients","volume":"83","author":"Hahn BH","year":"1975","unstructured":"Hahn BH, Kantor OS, Osterland CK. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients. Ann Intern Med. 1975, 83:597-605. 10.7326\/0003-4819-83-5-597","journal-title":"Ann Intern Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/BF01419725","article-title":"Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone","volume":"16","author":"Oelzner P","year":"1996","unstructured":"Oelzner P, Abendroth K, Hein G, Stein G. Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone. Rheumatol Int. 1996, 16:133-9. 10.1007\/BF01419725","journal-title":"Rheumatol Int"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/art.25052","article-title":"Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial","volume":"62","author":"Ginzler EM","year":"2010","unstructured":"Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis Rheum. 2010, 62:211-21. 10.1002\/art.25052","journal-title":"Arthritis Rheum"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.04.002","article-title":"Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review","volume":"44","author":"Cobo-Ib\u00e1\u00f1ez T","year":"2014","unstructured":"Cobo-Ib\u00e1\u00f1ez T, Loza-Santamar\u00eda E, Pego-Reigosa JM, et al.. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2014, 44:175-85. 10.1016\/j.semarthrit.2014.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Merrill JT","year":"2010","unstructured":"Merrill JT, Burgos-Vargas R, Westhovens R, et al.. The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010, 62:3077-87. 10.1002\/art.27601","journal-title":"Arthritis Rheum"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Wallace DJ","year":"2018","unstructured":"Wallace DJ, Furie RA, Tanaka Y, et al.. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet . 2018, 392:222-31. 10.1016\/S0140-6736(18)31363-1","journal-title":"Lancet"},{"key":"ref62","article-title":"The hand in systemic lupus erythematosus","volume":"5","author":"Dray GJ","year":"1989","unstructured":"Dray GJ. The hand in systemic lupus erythematosus. Hand Clin. 1989, 5:145-55.","journal-title":"Hand Clin"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1097\/00003086-197606000-00038","article-title":"Corrective surgery for the deforming hand arthropathy of systemic lupus erythematosus","author":"Schumacher HR","year":"1976","unstructured":"Schumacher HR, Zweiman B, Bora FW Jr. Corrective surgery for the deforming hand arthropathy of systemic lupus erythematosus. Clin Orthop Relat Res. 1976, 292-5.","journal-title":"Clin Orthop Relat Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/s1297-3203(00)73476-7","article-title":"Jaccoud\u2019s arthropathy","volume":"19","author":"Alnot JY","year":"2000","unstructured":"Alnot JY, Liverneaux P, Wodecki P. Jaccoud\u2019s arthropathy. Chir Main . 2000, 19:169-80. 10.1016\/s1297-3203(00)73476-7","journal-title":"Chir Main"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:25:1:25","article-title":"Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications","volume":"25","author":"Buskila D","year":"2003","unstructured":"Buskila D, Press J, Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol. 2003, 25:25-8. 10.1385\/CRIAI:25:1:25","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3351-9","article-title":"Severe Jaccoud's arthropathy in systemic lupus erythematosus","volume":"35","author":"Santiago MB","year":"2015","unstructured":"Santiago MB, Galv\u00e3o V, Ribeiro DS, et al.. Severe Jaccoud's arthropathy in systemic lupus erythematosus. Rheumatol Int. 2015, 35:1773-7. 10.1007\/s00296-015-3351-9","journal-title":"Rheumatol Int"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake R","year":"2001","unstructured":"Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2001, 60:67-8. 10.1136\/ard.60.1.67","journal-title":"Ann Rheum Dis"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315627199","article-title":"The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort","volume":"25","author":"Conti F","year":"2016","unstructured":"Conti F, Ceccarelli F, Perricone C, et al.. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. Lupus. 2016, 25:719-26. 10.1177\/0961203315627199","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181484-a-practical-overview-of-the-articular-manifestations-of-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:49Z","timestamp":1707509089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181484-a-practical-overview-of-the-articular-manifestations-of-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":68,"URL":"https:\/\/doi.org\/10.7759\/cureus.44964","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,9]]}}}